Search results for " cost" in Articles / App Notes
Article
Optimizing Late-Stage and Commercial Cell-Culture Processes
…control) have also contributed to increasing titers, maintaining consistent product quality, reduced cost of goods, and a decrease in facility footprints, Laird says.
Cell-culture hurdles
The…
Article
Miniaturization to Become Even More Successful
Industrial bioprocess development has changed significantly in the last decade, driven primarily by two major factors: ever-rising R&D costs of developing therapeutic candidates with simultaneous de…
Article
Biopharmaceutical Market in Asia: Q&A with Günter Jagschies, Strategic Customer Relations Leader, Cytiva
…cines, often with insufficient support from health insurance, for example, and dependent on very low cost offerings for their medication is an immense challenge. Competition, in particular in the bio…
Article
Taking Prepacked Columns to Manufacturing Scale
Prepacked chromatography columns in biomanufacturing can save time, but also present concerns related to delivery lead times, capacity, and operational cost.
Learn more here about ways to address…
Article
FDA Framework Spurs Advanced Therapies
In addition to manufacturing capacities as a whole, there will be a need for implementation of efficiencies to reduce cost of goods, facility footprints, and equipment overhead, Keene also asserts. Lo…
Article
Preclinical Evaluation of Product Related Impurities and Variants
This is equivalent to ~30 hours of instrument run time and costs more than $250/variant. The issue is further compounded by the fact that the collected fraction may or may not represent a pure isolate…
Article
Techniques for Improving Process Development for Exosome-Derived Therapeutics
… process, can become exosome drug therapeutics that are scalable, consistent, and have a competitive cost of goods to be a viable contender in medicine.
Here, the Process Development Forum sp…
Article
3rd BioProcessing Asia Preview: Q&A with John Curling
Polyclonal products are sold at a fraction of the price, a good reason to include fractionation in the program as an example of low cost manufacturing.
At BPA 2016, a presentation addressing chall…
Article
Transformative Medicines Challenge FDA and Manufacturers
Transformative Medicines Challenge FDA and Manufacturers
New gene therapies and combination products require innovative regulatory approaches.
By Jill Wechsler …
Article
Evaluating Surface Cleanliness Using a Risk-Based Approach
Surface sampling can add production delays, increased sampling costs, and often increased safety risk to the analyst. If the engineering of the equipment, coverage testing of the equipment, and cleani…